Hematopoietic SCT in Europe 2013: Recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

Bone Marrow Transplantation

Volumn 50, Issue 4, 2015, Pages 476-482

  Passweg, J R ^a   Baldomero, H ^a   Bader, P ^b   Bonini, C ^c   Cesaro, S ^d   Dreger, P ^e   Duarte, R F ^f   Dufour, C ^g   Falkenburg, J H F ^h   Farge Bancel, D ⁱ   Gennery, A ^j   Kroger N ^k   Lanza, F ^l   Nagler, A ^m   Sureda, A ^f   Mohty, M ⁿ  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d Paediatric Haematology Oncology   (Italy)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f HOSPITAL DURAN I REYNALS   (Spain)

^g G GASLINI INSTITUTE   (Italy)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ SAINT LOUIS HOSPITAL   (France)

^j NEWCASTLE UNIVERSITY   (United Kingdom)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l Hematology and BMT Unit   (Italy)

^m SHEBA MEDICAL CENTER   (Israel)

ⁿ HÔPITAL SAINT ANTOINE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; EUROPE; HAPLOIDENTICAL DONOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REVIEW; SIBLING; SOLID TUMOR; TREATMENT INDICATION; TREND STUDY; UNRELATED DONORS; ALLOGRAFT; AUTOGRAFT; CLINICAL TRIAL; FACTUAL DATABASE; FEMALE; MALE; MULTICENTER STUDY; NEOPLASMS;

ALLOGRAFTS; AUTOGRAFTS; CORD BLOOD STEM CELL TRANSPLANTATION; DATABASES, FACTUAL; EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; NEOPLASMS; UNRELATED DONORS;

EID: 84926420237     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.312     Document Type: Review

References (17)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826
2. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472-1475
3. Ljungman P, Bregni M, Brune M, Cornelissen J, deWitte T, Dini G, et al. European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010; 45: 219-234
4. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617-1624
5. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K, et al. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant 2011; 46: 174-191
6. Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for. Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1991; 8: 197-201
7. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua AAccreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374-2386
8. Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K, et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 275-291
9. Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D, et al. Changes in use of hematopoietic stem cell transplantation; a model for diffusion of medical technology. Haematologica 2010; 95: 637-643
10. Passweg JR, Baldomero H, Peters C, Gaspar H B, Cesaro S, Dreger P, et al. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant 2014; 49: 744-750
11. Martin I, Ireland H, Baldomero H, Passweg JR. The survey on cellular and engineered tissue therapies in Europe in 2012. Tissue Eng Part A 2014 (e-pub ahead of print
12. World Health Organisation, WHO (http://www.who.int/topics/transplantation/en/
13. Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M. Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant 2010; 45: 811-818
14. Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, et al. Blood and Marrow Transplant Clinical Trials Network. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011; 118: 282-288
15. Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLAhaploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14: 641-650
16. Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012; 47: 906-923
17. Eapen M, O'Donnell P, Brunstein CG, Wu J, Barowski K, Mendizabal A, et al. Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies. Biol Blood Marrow Transplant 2014; 20: 1485-1492